Chengdu Baiyu Pharmaceutical Co., Ltd.
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
May 2032
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jan 21, 2027The maintenance fee for Method for extracting and separating ginkgolides (US 9,084,755) comes due Jan 21, 2027. Unpaid by Jul 21, 2027, it lapses early.
- 1 fee due Apr 15, 2027The maintenance fee for Pharmaceutical composition containing Ginkgolide B and blood platelet prostaglandin cyclooxygenase inhibitor and method for preparation thereof and use thereof (US 10,441,599) comes due Apr 15, 2027. Unpaid by Oct 15, 2027, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 23, 2026
- Oct 20 US 12,767,624 Method for Purifying Cannabinoid Compounds
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 7 of 7
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,084,755 | Method for extracting and separating ginkgolides In force · USPTO record | In force | USPTO record | |
| US 10,441,599 | Pharmaceutical composition containing Ginkgolide B and blood platelet prostaglandin cyclooxygenase inhibitor and method for preparation thereof and use thereof In force · USPTO record | In force | USPTO record | |
| US 10,751,321 | Pharmaceutical composition containing Ginkgolide B and ADP receptor antagonist, preparation method thereof and use thereof In force · USPTO record | In force | USPTO record | |
| US 10,058,533 | Pharmaceutical composition containing Ginkgolide B and Xa factor inhibitor, preparation method thereof and use thereof In force · USPTO record | In force | USPTO record | |
| US 12,391,711 | Tetrahydrocannabinol derivatives, preparation method thereof and use thereof In force · USPTO record | In force | USPTO record | |
| US 12,767,624 | Method for Purifying Cannabinoid Compounds In force · High confidence | In force | High confidence | |
| US 12,545,694 | Cannabidiol Derivatives, Preparation Method Thereof and Use Thereof In force · High confidence | In force | High confidence |
Also on record, not counted in the 7: 1 patent in force now held by others · 1 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
5 pending · 1 no status recorded